No definition available.
Generalized skin eruption due to drugs and medicaments
GENERALI_SKIN_ERUPT_DRUGS_MEDICAM
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1472 |
4. Check minimum number of eventsNone |
1472 |
5. Include endpointsNone |
1472 |
6. Filter based on genotype QC (FinnGen only) |
1472 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Generalized skin eruption due to drugs and medicaments
based on the number of shared cases.
Similar with more cases:
- Acute generalized exanthematous pustulosis
- Dermatitis due to substances taken internally
- Dermatitis and eczema
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 11054 | 6550 | 4445 |
| Only index persons | 9672 | 5844 | 3828 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.16 | 0.19 | 0.12 |
| Only index persons | 0.19 | 0.21 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 49.28 | 52.61 | 44.11 |
| Only index persons | 48.96 | 51.80 | 44.62 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1472 | 965 | 507 |
| Unadjusted period prevalence (%) | 0.29 | 0.33 | 0.22 |
| Median age at first event (years) | 55.46 | 52.24 | 61.60 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1320
- Matched controls
- 13197
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
4503599627370496.0
323.0
1318
22
H02AB06
ATC
prednisolone; systemic
4.3
132.7
876
4165
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
6.7
115.6
330
626
XQ800
NOMESCO Finland
Prick test
5.4
71.3
236
513
R06AE07
ATC
cetirizine; oral
2.8
66.6
739
4170
L50.0
ICD-10 Finland
Allergic urticaria
10.4
58.9
119
124
XQ802
NOMESCO Finland
Epicutan test
7.7
58.5
143
206
J01FF01
ATC
clindamycin; systemic
2.8
58.0
483
2233
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.3
55.8
229
613
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
55.2
661
3743
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.1
53.2
344
1331
XQ820
NOMESCO Finland
Exposure to medicinal substance
52.3
50.3
60
12
E0000UV
ATC
NA
2.4
48.7
644
3752
D07AB08
ATC
desonide; topical
3.6
47.3
238
755
D07AC01
ATC
betamethasone; topical
2.4
44.7
534
2917
R50.9
ICD-10 Finland
Fever, unspecified
3.1
44.3
283
1068
XQ899
NOMESCO Finland
Other assessment of skin
40.2
43.1
54
14
T78.4
ICD-10 Finland
Allergy, unspecified
5.1
41.0
136
289
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
37.2
198
649
L50.9
ICD-10 Finland
Urticaria, unspecified
6.1
37.1
105
184
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
8.9
35.5
77
91
D07AA02
ATC
hydrocortisone; topical
2.8
34.7
259
1066
A02BC02
ATC
pantoprazole; systemic
2.1
34.6
855
6195
J01MA12
ATC
levofloxacin; systemic
2.6
34.4
290
1282
E000001
ATC
NA
2.3
32.2
355
1803
XQ801
NOMESCO Finland
Intracutantest
35.2
32.0
41
12
A46
ICD-10 Finland
Erysipelas
2.8
31.1
221
878
C01CA24
ATC
epinephrine; parenteral
3.8
31.1
139
393
D07AB02
ATC
hydrocortisone butyrate; topical
2.1
30.0
421
2374
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
29.3
470
2794
J01DB01
ATC
cefalexin; oral
2.2
28.7
1085
8948
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
28.5
337
1750
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
28.4
315
1588
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
9.5
27.1
56
61
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.8
26.8
193
770
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
25.0
220
980
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.9
24.6
163
616
L04AX01
ATC
azathioprine; systemic
4.2
23.8
94
238
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.0
23.8
98
258
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.1
23.7
96
249
D07AC13
ATC
mometasone; topical
1.9
22.5
400
2423
J01MA14
ATC
moxifloxacin; systemic
2.9
22.2
144
533
ZX120
NOMESCO Finland
Intravenous
2.7
22.1
158
622
N02AX02
ATC
tramadol; systemic, rectal
1.8
21.7
534
3609
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.6
21.6
76
172
J01MA02
ATC
ciprofloxacin; systemic
1.8
21.5
496
3278
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.0
21.5
89
235
N02AA05
ATC
oxycodone; systemic
2.4
21.5
200
912
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
21.1
377
2280
N03AG01
ATC
valproic acid; systemic, rectal
3.3
20.8
107
339
ZX108
NOMESCO Finland
Inhalation
13.2
20.7
36
28
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
20.7
207
978
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
13.8
20.6
35
26
H02AB07
ATC
prednisone; oral
2.3
20.4
210
1007
H02AB04
ATC
methylprednisolone; systemic
2.3
20.2
213
1032
P01BA02
ATC
hydroxychloroquine; oral
2.7
20.1
151
612
H02AB02
ATC
dexamethasone; systemic
2.5
20.0
165
705
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.0
20.0
121
430
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.0
19.5
117
413
N02BE01
ATC
paracetamol; systemic, rectal
1.9
19.3
1096
9464
L27.2
ICD-10 Finland
Dermatitis due to ingested food
8.9
19.0
40
46
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.0
18.8
114
405
L04AD01
ATC
ciclosporin; systemic
5.9
18.6
52
91
E000003
ATC
NA
3.4
18.5
93
289
C03CA01
ATC
furosemide; systemic
1.9
18.5
352
2157
N03AX16
ATC
pregabalin; oral
1.9
18.1
298
1730
R06AX27
ATC
desloratadine; oral
1.8
17.9
367
2302
D07AD01
ATC
clobetasol; topical
2.1
17.9
217
1117
J01DA01
ATC
[U] cefalexin; systemic
1.7
17.8
804
6371
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.8
17.7
119
452
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.9
17.5
109
391
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
17.4
293
1716
TQW80
NOMESCO Finland
Local dermatologic skincare
4.7
17.1
58
127
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
16.8
161
741
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
16.8
203
1041
L04AA06
ATC
mycophenolic acid; systemic
6.1
16.6
45
76
XW000
NOMESCO Finland
Bone marrow biopsy
3.6
16.4
75
217
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
16.2
291
1738
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.0
16.0
96
338
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.3
16.0
59
141
J01FA06
ATC
roxithromycin; oral
1.7
15.9
501
3554
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.3
15.8
81
256
E000006
ATC
NA
2.6
15.8
123
509
R06.0
ICD-10 Finland
Dyspnoea
1.8
15.8
312
1923
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
15.7
268
1569
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.0
15.6
50
103
L04AX04
ATC
lenalidomide; oral
17.4
15.6
24
14
A04AA01
ATC
ondansetron; systemic, rectal
2.7
15.5
113
450
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
15.4
122
508
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.8
15.3
294
1792
J01FA09
ATC
clarithromycin; systemic
1.7
15.3
402
2704
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.3
15.3
153
719
P01AB01
ATC
metronidazole; oral, rectal
1.6
15.2
496
3541
M04AA01
ATC
allopurinol; systemic
2.2
14.9
161
785
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.4
14.9
72
218
J05AB01
ATC
aciclovir; systemic
1.8
14.9
279
1686
R03AC02
ATC
salbutamol; inhalant
1.6
14.8
656
5059
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.5
14.6
69
205
N03AF01
ATC
carbamazepine; oral, rectal
3.1
14.6
83
283
L27.1
ICD-10 Finland
Localized skin eruption due to drugs and medicaments
14.4
14.6
24
17
R03DC03
ATC
montelukast; oral
2.0
14.5
206
1124
J05AB11
ATC
valaciclovir; oral
2.1
14.4
184
960
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
14.4
267
1603
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
22.5
14.2
20
9
153
Kela drug reimbursment
Lenalidomid
13.6
14.2
24
18
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
14.1
501
3640
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
14.0
558
4171
J01AA02
ATC
doxycycline; systemic
1.6
13.9
941
8003
JN4BD
NOMESCO Finland
Extensive body CT
2.2
13.8
146
703
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.3
13.8
71
226
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
13.6
130
598
L51.0
ICD-10 Finland
Nonbullous erythema multiforme
34.4
13.5
17
5
L26
ICD-10 Finland
Exfoliative dermatitis
26.0
13.4
18
7
J01XX08
ATC
linezolid; systemic
21.4
13.3
19
9
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.8
13.2
89
337
L50.8
ICD-10 Finland
Other urticaria
5.2
13.1
40
79
A07EC01
ATC
sulfasalazine; oral, rectal
2.4
13.1
114
500
R01AD08
ATC
fluticasone; nasal
1.7
13.1
353
2372
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.3
13.0
122
557
E000002
ATC
NA
2.0
13.0
172
913
A03
ICPC
Fever
1.9
13.0
216
1249
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
13.0
417
2936
SPAT1263
SPAT
Sampling
1.6
12.9
544
4095
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.8
12.9
55
151
N03AX09
ATC
lamotrigine; oral
3.1
12.9
73
247
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.3
12.8
120
546
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.8
12.8
42
90
R03BA02
ATC
budesonide; inhalant
1.8
12.8
229
1355
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
12.8
219
1278
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
12.7
442
3171
J01FA10
ATC
azithromycin; systemic
1.5
12.6
739
5995
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.0
12.5
50
130
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
12.5
96
395
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
12.5
154
793
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
12.5
225
1336
Z51.5
ICD-10 Finland
Palliative care
2.8
12.4
81
304
XQ848
NOMESCO Finland
Dermatological photography
4.1
12.3
47
117
L04AB04
ATC
adalimumab; parenteral
5.3
12.3
37
72
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
12.3
138
683
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
9.1
12.3
25
28
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
12.1
212
1242
NF1AA
NOMESCO Finland
Hip X-ray examination
2.3
12.1
120
561
N03AX12
ATC
gabapentin; oral
1.9
12.1
187
1051
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
12.0
532
4031
JN4AD
NOMESCO Finland
Body CT examination
2.4
12.0
101
434
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
12.0
352
2411
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
12.0
240
1473
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
11.9
120
567
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.2
11.9
119
559
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.4
11.8
100
434
R01AD09
ATC
mometasone; nasal
1.5
11.7
539
4111
XG410
NOMESCO Finland
Flow-volume spirometry
3.1
11.7
64
214
D02AX
ATC
Other emollients and protectives
3.0
11.7
67
230
L51.9
ICD-10 Finland
Erythema multiforme, unspecified
16.6
11.7
18
11
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.3
11.6
42
100
N03AX14
ATC
levetiracetam; systemic
3.7
11.5
49
135
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.9
11.5
46
120
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.4
11.5
98
425
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.9
11.5
170
941
L03AA02
ATC
filgrastim; parenteral
3.8
11.4
48
131
WW500
NOMESCO Finland
Blood transfusion
3.1
11.4
62
207
L04AA01
ATC
[U] ciclosporin; systemic
5.7
11.2
31
55
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
11.2
219
1333
A92
ICPC
Allergy/allergic reaction NOS
3.6
10.9
48
137
D07XC01
ATC
betamethasone, combinations; topical
2.0
10.7
145
776
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.9
10.6
42
109
S01GX01
ATC
cromoglicic acid; ophthalmic
1.7
10.6
248
1587
A04AA02
ATC
granisetron; systemic, transdermal
2.5
10.6
84
351
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.6
10.6
47
135
H02AB09
ATC
hydrocortisone; systemic
3.8
10.5
44
120
R06AX22
ATC
ebastine; oral
1.8
10.5
205
1242
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.1
10.5
56
185
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
10.5
116
570
A02BC03
ATC
lansoprazole; oral
1.6
10.2
346
2439
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.5
10.2
46
134
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.2
10.2
53
172
A02BC05
ATC
esomeprazole; systemic
1.5
10.2
464
3502
N05BA04
ATC
oxazepam; oral
1.6
10.1
295
2004
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.8
10.0
41
110
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
10.0
158
892
D05BB02
ATC
acitretin; oral
3.9
9.9
39
101
SPAT1254
SPAT
Administration of medicine
1.8
9.9
186
1113
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
9.8
497
3832
L20.0
ICD-10 Finland
Besnier prurigo
2.2
9.7
100
477
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
55.4
9.7
11
*
L27.9
ICD-10 Finland
Dermatitis due to unspecified substance taken internally
55.4
9.7
11
*
J02AC01
ATC
fluconazole; systemic
1.5
9.6
494
3814
R06AE09
ATC
levocetirizine; oral
1.8
9.6
189
1148
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
4.6
9.6
32
71
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.9
9.6
57
203
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
9.5
212
1335
C90.0
ICD-10 Finland
Multiple myeloma
6.0
9.5
25
42
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
9.5
128
682
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.9
9.5
55
192
Z88.1
ICD-10 Finland
Personal history of allergy to other antibiotic agents
100.7
9.4
10
*
A28
ICPC
Limited function/disability NOS
1.8
9.4
165
965
1CX01
NOMESCO Finland
NA
21.9
9.4
13
6
N03AF02
ATC
oxcarbazepine; oral
2.8
9.3
56
202
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.9
9.3
37
98
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
9.0
174
1047
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
15.7
9.0
14
9
SPAT1255
SPAT
Intravenous administration of medicine
2.3
9.0
85
389
N03AX18
ATC
lacosamide; systemic
10.1
9.0
17
17
C91.4
ICD-10 Finland
Hairy-cell leukaemia
36.9
9.0
11
*
M54.5
ICD-10 Finland
Low back pain
1.5
9.0
381
2814
WW200
NOMESCO Finland
Immunization
3.3
8.8
43
134
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
8.7
189
1179
C07AB07
ATC
bisoprolol; oral
1.4
8.6
506
3986
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
8.6
318
2277
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.6
8.6
62
248
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
8.6
165
995
AA1AD
NOMESCO Finland
CT of head and brain
1.6
8.6
265
1822
329
Kela drug reimbursment
Lenalidomide
16.4
8.6
13
8
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.3
8.6
80
367
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
8.5
100
503
R51.80
ICD-10 Finland
Headache
1.7
8.5
174
1068
M05BX04
ATC
denosumab; parenteral
2.5
8.5
64
261
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
4.4
8.4
29
67
M25.5
ICD-10 Finland
Pain in joint
1.5
8.4
327
2365
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
12.8
8.4
14
11
S97
ICPC
Chronic ulcer skin
2.4
8.4
70
303
S88
ICPC
Dermatitis contact/allergic
3.4
8.3
38
113
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
5.3
8.3
24
46
D02AE01
ATC
carbamide; topical
2.1
8.3
92
454
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.8
8.3
33
88
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.0
8.3
98
497
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
8.2
92
457
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
8.2
77
353
R60.0
ICD-10 Finland
Localized oedema
1.9
8.2
127
712
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
8.1
609
5005
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
2.3
8.1
71
314
L30.3
ICD-10 Finland
Infective dermatitis
2.9
8.1
47
165
R53
ICD-10 Finland
Malaise and fatigue
1.6
8.1
242
1646
R11
ICD-10 Finland
Nausea and vomiting
2.0
8.1
107
566
L40.1
ICD-10 Finland
Generalized pustular psoriasis
33.6
8.1
10
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.2
8.1
79
370
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
8.0
157
951
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
3.5
8.0
36
106
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.9
8.0
46
160
S76
ICPC
Skin infection other
2.4
8.0
65
279
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.9
8.0
46
161
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.1
8.0
92
463
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
8.0
114
622
D07CC01
ATC
betamethasone and antibiotics; topical
1.7
7.9
156
947
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
7.9
48
175
R03AC03
ATC
terbutaline; inhalant
1.7
7.9
170
1059
UJF32
NOMESCO Finland
Coloscopy
1.5
7.9
279
1974
S18
ICPC
Laceration/cut
1.4
7.9
473
3728
WZC30
NOMESCO Finland
Teaching
1.7
7.9
149
896
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
7.8
72
329
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
4.5
7.8
26
59
C08CA01
ATC
amlodipine; oral
1.5
7.8
366
2753
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
7.7
97
506
B01AB05
ATC
enoxaparin; parenteral
1.5
7.7
343
2548
127
Kela drug reimbursment
Transplant complication
4.1
7.7
28
69
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
7.7
154
942
R06AX13
ATC
loratadine; oral
1.7
7.7
182
1165
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.9
7.6
102
544
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
25.2
7.6
10
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
7.6
97
508
N05CF01
ATC
zopiclone; oral
1.5
7.5
352
2637
A07AA02
ATC
nystatin; oral
2.2
7.5
77
366
J47
ICD-10 Finland
Bronchiectasis
4.2
7.5
27
66
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.5
7.5
310
2267
L04AA13
ATC
leflunomide; oral
3.1
7.5
39
129
B01AB10
ATC
tinzaparin; parenteral
2.0
7.4
88
447
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
7.4
143
863
R42
ICD-10 Finland
Dizziness and giddiness
1.5
7.4
241
1671
B02.9
ICD-10 Finland
Zoster without complication
2.2
7.4
69
317
WX110
NOMESCO Finland
Local anesthesy
1.4
7.3
821
7174
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
7.3
338
2527
L93.0
ICD-10 Finland
Discoid lupus erythematosus
10.9
7.3
13
12
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.6
7.3
31
88
A02BC01
ATC
omeprazole; systemic
1.5
7.3
309
2271
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
+∞
7.3
7
*
N06AX21
ATC
duloxetine; oral
1.8
7.3
116
657
TGC00
NOMESCO Finland
Bronchial lavation
3.2
7.3
36
115
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.6
7.2
50
195
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
7.2
59
253
A07EA06
ATC
budesonide; oral, local oral
2.9
7.2
42
150
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
7.2
183
1195
M79.6
ICD-10 Finland
Pain in limb
1.4
7.2
403
3128
M05BA04
ATC
alendronic acid; oral
1.9
7.2
100
542
YNB10
NOMESCO Finland
Collection of stem cells for transplant
30.2
7.2
9
*
SPAT1325
SPAT
Vaccination
1.4
7.1
405
3144
L50
ICD-10 Finland
Urticaria
4.1
7.1
26
65
UDM02
NOMESCO Finland
Sinoscopy
3.7
7.1
29
80
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
7.1
373
2859
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.4
7.1
32
96
C08CA13
ATC
lercanidipine; oral
1.7
7.0
135
815
SPAT1301
SPAT
No procedures
1.4
7.0
367
2810
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
7.0
239
1675
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
6.9
52
214
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
6.9
593
4936
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.3
6.9
24
57
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
6.9
73
354
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
6.9
165
1061
D07BC01
ATC
betamethasone and antiseptics; topical
1.7
6.9
133
803
J01FA01
ATC
erythromycin; systemic
1.6
6.9
168
1086
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
4.4
6.9
23
53
L40.5
ICD-10 Finland
Arthropathic psoriasis
4.0
6.8
25
63
R01AD12
ATC
fluticasone furoate; nasal
1.4
6.8
330
2485
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
6.1
6.8
17
28
J01CA04
ATC
amoxicillin; systemic
1.4
6.7
1007
9172
L04AB01
ATC
etanercept; parenteral
4.1
6.7
24
59
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.6
6.7
154
979
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
6.7
152
961
B01AC04
ATC
clopidogrel; oral
1.6
6.6
157
1006
L50.1
ICD-10 Finland
Idiopathic urticaria
6.5
6.6
16
25
M03BX02
ATC
tizanidine; oral
1.3
6.6
682
5834
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
6.6
176
1158
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.3
6.6
61
277
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
6.6
185
1238
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.2
6.6
64
300
ZX112
NOMESCO Finland
Subcutaneous
3.1
6.6
33
107
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
3.9
6.6
25
65
M13.9
ICD-10 Finland
Arthritis, unspecified
2.0
6.6
84
443
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.8
6.5
20
42
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.6
6.5
27
76
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
6.5
111
646
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
4.5
6.5
21
47
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.6
6.4
43
168
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.7
6.4
134
828
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.9
6.4
35
121
6960A
ICD-9 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
14.4
6.4
10
7
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.1
6.4
69
339
H05AA02
ATC
teriparatide; parenteral
8.2
6.3
13
16
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.2
6.3
59
270
L04AC05
ATC
ustekinumab; parenteral
11.1
6.3
11
10
R03AK08
ATC
formoterol and beclometasone; inhalant
2.5
6.3
45
182
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
18.1
6.3
9
5
L51.19
ICD-10 Finland
Other bullous erythema multiforme
+∞
6.3
6
*
R02
ICPC
Shortness of breath/dyspnoea
1.7
6.2
131
813
X57
ICD-10 Finland
Unspecified privation
3.1
6.2
31
101
XG466
NOMESCO Finland
Sleep oxymetry
2.8
6.2
37
135
D70.82
ICD-10 Finland
Drug-induced neutropenia
3.7
6.2
25
69
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
6.2
317
2408
Z71.8
ICD-10 Finland
Other specified counselling
1.4
6.1
275
2040
K07
ICPC
Swollen ankles/oedema
2.4
6.1
47
198
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
3.9
6.1
23
60
128
Kela drug reimbursment
Cancers of female genital organs
3.3
6.1
28
86
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
3.1
6.1
30
97
A06AD11
ATC
lactulose; oral
1.6
6.1
151
978
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
8.6
6.1
12
14
134
Kela drug reimbursment
General erythroderma
8.6
6.1
12
14
SPAT1153
SPAT
Removal of sutures
1.4
6.0
352
2736
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
6.7
6.0
14
21
WX002
NOMESCO Finland
Sedation and analgesia
1.5
6.0
219
1553
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
4.2
6.0
21
51
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.7
6.0
39
148
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
47
13
37.31
75.42
1.0
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
598
3010
2.66
69.40
6.4
4.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
931
6008
2.50
60.83
11.5
5.9
e9/l
0.0
0.0
0.05
854
5191
(3001604) Monocytes [#/volume] in Blood
927
5982
2.48
60.39
11.5
5.9
e9/l
0.6
0.6
0.56
851
5160
(3013115) Eosinophils [#/volume] in Blood
952
6219
2.50
60.35
11.9
6.1
e9/l
0.2
0.2
2.08
880
5453
(42870588) Differential panel, method unspecified - Blood
703
4046
2.41
58.71
11.5
5.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
938
6176
2.43
57.00
11.6
5.9
e9/l
2.0
1.9
0.09
876
5439
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
106
198
5.69
54.70
2.1
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
173
486
3.90
53.98
1.3
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1010
6971
2.43
53.64
16.8
8.8
e9/l
4.2
4.1
1.46
931
6088
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
123
274
4.81
51.94
2.2
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
113
235
5.13
51.74
7.7
6.0
iu/ml
333.7
314.8
0.04
23
32
(3005719) IgG [Mass/volume] in Serum or Plasma
253
929
3.08
51.73
4.5
2.9
g/l
10.1
10.5
0.50
242
847
(3022096) Basophils/100 leukocytes in Blood
840
5472
2.25
49.43
12.3
6.0
%
0.7
0.7
0.02
795
5102
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
119
269
4.72
49.33
2.2
1.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
861
5681
2.24
48.87
12.6
6.3
%
8.4
8.5
0.26
817
5314
(3006504) Eosinophils/100 leukocytes in Blood
855
5651
2.22
47.98
12.3
6.0
%
3.0
2.8
1.14
812
5252
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
385
1854
2.46
45.85
2.4
1.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
869
5850
2.19
45.64
12.4
6.1
%
26.6
28.3
4.05
823
5452
(3018010) Neutrophils/100 leukocytes in Blood
860
5772
2.18
45.43
11.7
5.8
%
58.5
57.0
2.82
815
5401
(3011412) CD3 cells [#/volume] in Blood
72
111
6.77
44.96
2.8
2.7
e9/l
1.2
1.3
0.15
48
64
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
886
6031
2.18
44.94
9.8
6.0
umol/l
10.4
11.2
1.54
852
5710
(3028026) IgM [Mass/volume] in Serum or Plasma
203
730
3.07
42.63
2.5
1.9
g/l
1.2
1.5
1.07
187
674
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
59
78
7.84
42.25
2.5
2.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
284
1248
2.58
40.63
6.6
4.2
u/l
247.9
251.0
0.12
265
1175
(3017181) Myelocytes/100 leukocytes in Blood
242
986
2.74
40.27
6.6
4.1
%
0.8
1.0
0.54
124
277
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
59
84
7.28
39.60
2.3
2.8
%
13.0
11.0
0.34
24
44
(3002179) Metamyelocytes/100 leukocytes in Blood
225
895
2.79
39.15
6.4
3.9
%
0.5
0.6
0.58
98
205
(21494815) CD4 cells/100 lymphocytes in Specimen
62
95
6.77
38.91
1.9
2.5
%
40.7
42.2
—
7
14
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
836
5754
2.05
38.80
11.9
6.6
mmol/l
1.2
1.2
0.98
703
4876
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
778
5250
2.02
37.79
10.0
6.0
mmol/l
1.2
1.2
2.55
709
4760
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
140
432
3.48
37.67
2.5
1.9
ug/l
1.3
2.0
0.43
126
381
(3037522) Nuclear Ab [Titer] in Serum
330
1606
2.36
37.53
1.6
1.3
titre
657.9
509.8
0.59
85
328
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
124
361
3.66
36.42
2.9
1.6
g/l
0.2
0.2
0.51
114
344
(3005322) IgE [Units/volume] in Serum or Plasma
202
793
2.79
35.90
1.6
1.3
u/ml
424.5
207.1
1.35
190
727
(3021440) Promyelocytes/100 leukocytes in Blood
225
935
2.66
35.78
6.8
4.2
%
0.1
0.1
0.59
112
254
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
76
154
5.15
35.74
2.2
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
225
937
2.65
35.62
4.1
2.7
e9/l
70.7
69.9
0.10
175
710
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
125
373
3.57
35.37
2.9
1.5
g/l
1.1
1.2
1.40
118
352
(3025159) Blasts/100 leukocytes in Blood
213
879
2.66
34.27
6.7
4.3
%
0.9
0.5
0.19
101
217
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1139
8994
2.18
33.92
14.4
7.2
u/l
81.1
78.2
0.97
1096
8453
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
205
837
2.68
33.66
2.0
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
63
114
5.73
33.51
2.1
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
66
126
5.44
33.15
2.0
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
675
4473
1.94
33.09
8.7
8.8
inr
1.2
1.2
0.85
207
1318
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
81
188
4.50
32.38
3.8
3.7
u/ml
849.0
1949.0
—
6
15
(3007853) Bacteria identified in Skin by Aerobe culture
285
1401
2.28
31.13
2.0
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
268
1289
2.32
30.79
2.2
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
65
131
5.14
30.74
2.1
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
266
1281
2.31
30.44
2.1
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
53
89
6.14
30.43
1.7
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
264
1270
2.31
30.28
3.7
2.9
%
1.9
1.8
0.44
235
1128
(3020779) Urea [Moles/volume] in Serum or Plasma
220
979
2.47
30.06
11.6
7.6
mmol/l
9.8
9.5
0.26
209
934
(3004809) Band form neutrophils/100 leukocytes in Blood
76
179
4.42
29.82
3.0
3.1
%
1.6
1.3
0.26
65
145
(3024561) Albumin [Mass/volume] in Serum or Plasma
718
4974
1.87
29.65
8.2
4.7
g/l
34.5
35.7
5.94
664
4631
(3012095) Magnesium [Moles/volume] in Serum or Plasma
338
1821
2.11
29.16
6.1
3.5
mmol/l
0.8
0.8
1.41
324
1703
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
113
359
3.33
28.92
3.1
2.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
240
1141
2.32
28.16
3.1
2.0
nmol/l
335.1
375.0
2.23
225
1050
(3022948) Iron [Moles/volume] in Serum or Plasma
334
1816
2.09
28.00
3.1
2.4
umol/l
12.0
13.2
2.34
310
1670
(3042936) Bacteria identified in Isolate by Culture
313
1672
2.11
27.45
2.8
2.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
311
1664
2.10
27.12
3.0
2.4
g/l
2.3
2.3
1.30
285
1540
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
113
374
3.19
27.03
1.9
1.6
titre
217.8
150.0
—
9
14
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
293
1539
2.13
26.79
3.1
2.4
%
21.9
22.9
0.57
249
1314
(3031040) Bacteria [#/volume] in Urine by Automated count
1018
8028
1.87
26.19
6.0
4.5
e6/l
34.1
2744.9
—
9
109
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
77
205
3.91
25.66
1.9
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
624
4271
1.80
25.64
4.4
3.6
ng/l
51.2
44.2
0.21
453
2846
(3003458) Phosphate [Moles/volume] in Serum or Plasma
286
1513
2.10
25.56
9.6
5.7
mmol/l
1.1
1.1
0.69
266
1391
(21494814) CD8 cells/100 lymphocytes in Specimen
33
40
8.42
25.31
1.9
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
435
2679
1.89
25.07
8.5
4.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
890
6796
1.78
24.80
7.0
4.7
mmol/l
6.7
6.6
0.37
853
6302
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
64
154
4.30
24.43
1.9
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
63
150
4.34
24.38
1.8
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
517
3387
1.81
24.27
2.7
2.2
u/l
157.5
241.3
1.72
488
3187
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
46
85
5.55
23.93
3.2
2.8
e6/l
605.0
594.2
0.03
40
74
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
45
82
5.63
23.76
3.3
2.9
e9/l
0.2
0.2
0.26
40
73
(3037467) Urinalysis macro (dipstick) panel - Urine
1036
8345
1.82
23.33
6.5
4.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1077
8788
1.84
23.11
7.5
4.0
mm/h
15.4
11.9
8.86
1012
8119
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
538
3612
1.77
22.96
3.6
2.5
u/l
54.3
56.6
0.89
505
3339
(3017143) Hepatitis C virus Ab [Presence] in Serum
272
1469
2.04
22.78
2.0
1.5
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
27
30
9.15
22.12
2.0
2.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
192
920
2.25
21.83
5.6
2.9
g/l
65.5
66.7
1.17
176
836
(3007164) IgA [Mass/volume] in Serum or Plasma
406
2546
1.82
21.56
2.1
1.5
g/l
2.2
2.3
0.46
290
1531
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
48
102
4.83
21.36
1.9
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
48
102
4.83
21.36
1.9
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
48
102
4.83
21.36
1.9
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
468
3072
1.77
21.25
2.7
2.2
mg/l
3.1
2.9
1.24
396
2610
(3028433) Virus identified in Specimen by Culture
31
43
7.34
21.24
1.2
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
447
2897
1.78
21.19
4.1
2.7
umol/l
2914.0
5946.8
1.05
395
2519
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
479
3173
1.76
21.02
3.8
3.0
ng/l
1658.2
1228.7
1.01
412
2689
(44790049)
56
137
4.21
20.93
1.9
1.6
—
—
—
0
0
(44806118)
56
137
4.21
20.93
1.9
1.6
—
—
—
0
0
(44790048)
56
137
4.21
20.93
1.9
1.6
—
—
—
0
0
(44790047)
56
137
4.21
20.93
1.9
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
92
314
3.06
20.87
1.4
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
57
142
4.14
20.80
4.0
3.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
64
175
3.78
20.55
1.9
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
48
106
4.65
20.41
3.4
2.5
%
60.0
57.1
0.32
37
75
(3004588) Protein electrophoresis panel - Serum or Plasma
165
763
2.31
20.36
4.3
2.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
102
374
2.86
20.36
1.7
1.6
iu/ml
3.8
0.2
0.56
16
68
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
79
250
3.28
20.32
4.2
3.9
%
59.0
57.2
0.47
79
250
(3021879) Hepatitis B virus core Ab [Presence] in Serum
190
935
2.19
20.17
1.6
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
101
372
2.84
19.99
4.3
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
502
3413
1.71
19.83
6.4
3.9
ph
7.4
7.4
0.35
105
638
(3042111) Morphology [Interpretation] in Bone marrow Narrative
64
180
3.67
19.74
1.9
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
163
762
2.28
19.59
7.0
4.2
ph
7.4
7.4
0.05
17
88
(3015171) Extractable nuclear Ab [Units/volume] in Serum
113
447
2.66
19.50
1.4
1.2
u/ml
0.3
1.0
0.70
11
32
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
19
15
12.82
19.45
1.2
3.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
41
83
5.05
19.31
2.2
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
210
1094
2.07
19.19
3.2
2.3
g/l
0.2
0.2
0.40
188
1017
(3044640) Blood type and Crossmatch panel - Blood
538
3752
1.68
19.19
3.3
2.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
248
1372
1.97
19.17
2.0
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
75
239
3.25
19.08
3.9
3.6
e9/l
4.4
4.2
0.34
75
239
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
163
771
2.25
19.03
7.0
4.2
kpa
5.1
5.1
0.11
153
723
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
43
92
4.78
18.99
2.5
2.3
e6/l
623.0
724.7
0.34
20
38
(3035350) Ketones [Presence] in Urine by Test strip
774
5935
1.64
18.96
5.1
3.6
estimate
0.0
0.0
0.00
164
1144
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
157
736
2.27
18.72
6.9
4.2
mmol/l
1.7
1.8
0.10
120
548
(3030467) Casts [#/volume] in Urine by Automated count
479
3266
1.69
18.45
4.2
3.1
e6/l
0.3
0.4
1.17
393
2459
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
118
494
2.51
18.13
2.2
1.9
g/l
1.6
1.5
0.67
106
431
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
408
2675
1.73
18.09
2.0
1.8
mg/l
1.2
1.2
0.27
330
2028
(3018095) Leukocytes [#/volume] in Urine
586
4229
1.64
18.01
4.7
3.7
e6/l
42.0
92.3
1.96
442
2954
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
75
250
3.11
17.72
1.9
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
769
5955
1.61
17.56
6.7
5.0
estimate
0.0
0.0
0.50
174
1160
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
80
280
2.96
17.37
1.5
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
774
6015
1.60
17.33
5.2
3.7
estimate
0.0
0.0
0.80
167
1129
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
21
5
42.53
17.30
1.1
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
448
3043
1.68
17.29
12.9
6.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
110
457
2.52
17.17
1.5
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
383
2505
1.71
16.97
3.6
2.6
e6/l
5.0
6.8
2.75
349
2211
(3037756) Immunofixation for Serum or Plasma
74
254
3.01
16.63
2.7
1.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
97
385
2.63
16.63
2.1
2.2
ug/l
179.3
455.6
1.26
87
363
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
79
282
2.90
16.57
1.5
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
363
2354
1.72
16.53
3.9
2.7
mosm/kgh2o
509.4
544.1
2.36
324
2008
(3021589) Normoblasts [#/volume] in Blood
700
5352
1.59
16.49
18.5
9.2
e9/l
0.0
0.0
0.06
601
4367
(36304419) Bacteria [Presence] in Urine
462
3203
1.64
16.29
4.1
3.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
92
360
2.66
16.22
2.7
3.3
g/l
3.8
3.6
0.74
86
341
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
660
4999
1.58
16.04
2.8
2.3
nmol/l
75.1
76.7
0.79
604
4504
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
75
265
2.93
16.02
1.7
1.3
u/ml
363.0
244.0
1.53
48
149
(3001122) Ferritin [Mass/volume] in Serum or Plasma
715
5523
1.57
15.91
3.8
2.8
ug/l
165.3
113.4
1.38
659
5110
(3002582) Erythrocytes [#/volume] in Urine
498
3547
1.61
15.60
4.4
3.2
e6/l
31.5
79.6
1.61
415
2727
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
68
231
3.04
15.57
1.9
1.5
u/ml
120.2
112.1
0.39
16
39
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
418
2853
1.65
15.55
3.3
2.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
25
39
6.50
15.40
1.4
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
285
1760
1.77
15.31
2.6
2.2
s
29.7
29.6
0.03
273
1707
(40761535) Cells panel - Urine sediment
178
946
2.00
15.26
5.0
3.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
142
700
2.14
14.90
1.6
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
57
179
3.27
14.88
2.1
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
105
457
2.40
14.82
2.5
1.8
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
32
66
4.93
14.77
2.9
2.8
%
30.0
44.3
1.92
13
18
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
85
336
2.62
14.70
5.9
3.9
ratio
8.4
1.8
—
10
28
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
27
48
5.71
14.64
2.2
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
27
48
5.71
14.64
2.2
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1321
11991
1.99
14.51
28.7
13.4
mg/l
21.4
23.0
1.25
1183
9430
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
112
507
2.31
14.46
8.4
4.6
mmol/l
24.7
24.8
0.12
104
484
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
21
29
7.33
14.42
1.2
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
134
654
2.15
14.41
1.9
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
30
60
5.08
14.34
2.2
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
30
60
5.08
14.34
2.2
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
30
60
5.08
14.34
2.2
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
30
60
5.08
14.34
2.2
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
27
49
5.59
14.33
2.3
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
85
342
2.58
14.19
6.0
4.0
mg/l
52.6
69.6
0.36
66
279
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
85
342
2.58
14.19
6.0
4.0
mg/l
48.2
64.2
0.26
66
280
(3008536) Aspergillus sp Ab [Presence] in Serum
19
24
8.01
14.04
2.0
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
322
2102
1.68
14.03
2.0
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
69
253
2.81
13.80
6.4
4.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
374
2548
1.63
13.76
2.2
1.9
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
82
330
2.57
13.68
2.4
2.2
mg/l
13.9
11.6
0.76
76
298
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
95
410
2.41
13.67
2.1
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
319
2106
1.66
13.23
1.9
1.7
nmol/l
1232.6
1187.8
0.35
243
1573
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
713
5652
1.51
13.17
5.4
4.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
63
226
2.87
13.13
4.4
3.7
—
—
—
0
0
(3012544) pH of Venous blood
191
1096
1.85
12.96
6.1
4.4
—
7.4
—
0
5
(3026008) Bacteria identified in Urine by Culture
508
3763
1.53
12.85
4.0
3.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
44
129
3.49
12.82
1.3
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
55
187
3.02
12.61
1.6
1.7
g/l
0.4
0.8
2.52
36
139
(3020891) Body temperature
96
432
2.31
12.58
6.4
4.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
446
3225
1.55
12.53
5.9
3.9
estimate
0.0
0.0
1.28
160
1125
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
64
239
2.75
12.39
1.6
1.2
u/ml
3.6
6.4
—
7
18
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
108
514
2.19
12.37
2.4
2.0
u/l
38.5
39.0
0.09
95
454
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
79
328
2.49
12.37
1.6
1.2
u/ml
16.9
38.2
0.54
11
17
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
74
298
2.56
12.35
1.6
1.2
u/ml
18.5
2.6
0.57
16
33
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
75
305
2.54
12.27
1.6
1.2
u/ml
31.0
8.7
0.90
22
48
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
596
4601
1.50
12.24
5.6
3.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
185
1070
1.83
12.21
6.8
4.4
mmol/l
1.9
1.9
0.13
154
843
(3019060) Gas panel - Arterial blood
138
725
2.00
12.17
5.5
5.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
200
1190
1.79
12.02
4.6
3.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
116
575
2.10
11.98
8.6
4.4
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
22
40
5.57
11.66
2.1
3.5
e6/l
273.6
213.3
0.25
11
24
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
73
4.17
11.36
2.3
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
29
69
4.27
11.30
1.1
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
52
184
2.89
11.14
1.1
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
386
2767
1.54
11.06
4.9
3.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
356
2509
1.55
11.01
1.6
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
244
1573
1.66
10.93
3.2
2.4
ug/g
129.8
114.9
0.41
191
1227
(3019225) pH of Specimen
186
1115
1.76
10.86
8.0
3.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
525
4026
1.47
10.79
4.5
3.3
mmol/l
2.3
2.4
2.40
458
3525
(3003396) Base excess in Arterial blood by calculation
204
1258
1.72
10.78
8.7
7.6
mmol/l
1.3
1.1
0.23
152
981
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
26
59
4.47
10.75
2.5
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
204
1260
1.72
10.72
8.9
7.6
kpa
5.0
5.1
0.70
190
1207
(3027801) Oxygen [Partial pressure] in Arterial blood
204
1260
1.72
10.72
8.9
7.6
kpa
12.3
12.2
0.08
189
1208
(3033658) Prothrombin time (PT) actual/Normal
402
2925
1.52
10.68
6.4
3.9
%
91.3
90.8
0.12
390
2842
(3007566) Smooth muscle Ab [Titer] in Serum
72
307
2.41
10.68
1.3
1.2
titre
38.0
75.4
—
5
28
(3037121) Protein [Mass/volume] in Urine
89
417
2.21
10.61
4.4
3.3
g/l
0.3
0.3
0.08
47
169
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
27
64
4.28
10.58
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
27
64
4.28
10.58
1.1
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
302
2067
1.58
10.57
1.3
1.3
iu/ml
27.2
29.8
0.20
91
650
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
41
131
3.19
10.47
1.6
1.6
%
56.9
58.7
0.09
28
89
(3045142) Bone marrow Pathology biopsy report
40
126
3.24
10.46
1.5
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
37
111
3.39
10.44
1.5
1.3
g/l
0.4
0.4
0.30
22
75
(3027135) IgG subclass 1 [Mass/volume] in Serum
37
111
3.39
10.44
1.5
1.3
g/l
5.9
7.0
0.72
22
77
(3028192) IgG subclass 2 [Mass/volume] in Serum
37
111
3.39
10.44
1.5
1.3
g/l
1.9
2.7
1.59
21
75
(3025941) Bacteria identified in Stool by Culture
127
684
1.94
10.43
1.6
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
501
3827
1.47
10.42
5.6
3.2
u/l
33.7
31.0
0.59
473
3644
(3034770) Mitochondria Ab [Titer] in Serum
73
317
2.37
10.40
1.2
1.2
—
676.7
—
0
9
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
63
256
2.53
10.36
1.5
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
127
689
1.92
10.20
8.3
7.4
mmol/l
24.6
24.5
0.21
117
649
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
290
1982
1.58
10.18
1.2
1.2
u/ml
11.6
10.7
0.07
106
762
(3023419) Bacteria identified in Sputum by Culture
42
139
3.08
10.13
5.9
2.9
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
20
38
5.32
10.12
3.6
2.0
—
—
—
0
0
(4062490)
37
114
3.30
10.03
1.5
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
184
1125
1.73
10.00
9.2
8.1
%
95.6
95.6
0.02
171
1090
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
25
59
4.29
9.86
2.6
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
56
221
2.59
9.78
2.3
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
340
2428
1.52
9.75
1.7
1.7
pmol/l
127817336.6
31780300.1
0.85
284
2017
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
28
73
3.89
9.70
1.8
1.4
u/ml
39.4
20.6
—
5
10
(3000991) Gas panel - Venous blood
161
956
1.77
9.69
11.6
8.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
51
194
2.69
9.59
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
43
150
2.92
9.49
3.8
2.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
363
2647
1.49
9.37
5.2
4.0
kg/l
1.0
1.0
0.28
42
376
(3017704) Immunofixation for Urine
27
71
3.86
9.25
1.3
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
56
228
2.51
9.20
1.9
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
46
170
2.76
9.15
1.2
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1306
12122
1.69
9.14
28.6
15.4
mmol/l
139.3
139.6
3.12
1282
11783
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
58
241
2.46
9.13
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
153
911
1.76
9.12
3.7
2.7
ml/min/173m2
62.9
66.6
0.53
70
363
(3014576) Chloride [Moles/volume] in Serum or Plasma
212
1382
1.62
9.00
9.9
6.7
mmol/l
103.9
104.3
0.45
206
1346
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
392
2924
1.46
8.97
1.3
1.3
u/ml
1.2
1.7
0.58
95
754
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
303
2146
1.52
8.96
4.6
3.7
ng/l
145.6
388.1
2.49
218
1608
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
23
55
4.23
8.93
2.4
4.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
65
289
2.31
8.82
1.6
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
205
1333
1.62
8.79
5.0
2.9
umol/l
5.9
7.8
1.48
178
1139
(3023103) Potassium [Moles/volume] in Serum or Plasma
1306
12149
1.66
8.72
28.9
15.5
mmol/l
4.0
4.0
0.35
1283
11788
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
281
1976
1.52
8.56
3.2
2.7
e6/l
1.0
1.1
0.18
181
1107
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
128
737
1.81
8.55
1.3
1.3
au/ml
41.4
40.1
—
7
36
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
22
54
4.12
8.27
1.3
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
165
1035
1.67
8.13
10.2
8.3
g/l
117.9
120.6
0.94
158
1002
(3017732) Neutrophils [#/volume] in Blood
138
826
1.74
8.08
4.3
2.8
e9/l
4.3
4.2
0.32
101
651
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
38
136
2.84
8.05
1.2
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
16
31
5.21
7.93
4.9
4.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
207
1383
1.58
7.90
21.3
24.6
inr
1.4
1.2
0.61
25
180
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
23
61
3.81
7.81
1.7
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
44
173
2.59
7.80
1.1
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
23
62
3.75
7.64
1.7
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
54
237
2.33
7.58
5.3
4.0
mmol/l
2.2
2.6
0.56
37
157
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
578
4733
1.36
7.45
2.2
1.9
pmol/l
96.9
95.1
0.41
349
2430
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
134
816
1.71
7.38
2.5
2.4
au/ml
23.0
25.1
0.09
11
49
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
82
429
1.97
7.37
4.5
2.5
g/l
3.6
3.8
1.01
54
319
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
31
104
3.02
7.37
1.4
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
82
430
1.96
7.32
4.5
2.5
g/l
7.3
7.4
0.23
56
333
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
82
430
1.96
7.32
4.5
2.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
51
222
2.34
7.30
3.3
2.5
%
15.9
16.2
0.15
28
115
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
66
321
2.11
7.24
2.2
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
148
932
1.65
7.18
7.5
3.5
mmol/l
1.2
1.2
0.51
132
801
(3014111) Lactate [Moles/volume] in Serum or Plasma
154
980
1.64
7.18
8.9
7.2
mmol/l
1.6
1.4
0.95
148
936
(4035726)
154
980
1.64
7.18
1.5
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
28
90
3.15
7.15
1.7
1.4
%
38.8
34.4
0.22
21
60
(21494890) Protein electrophoresis panel - 24 hour Urine
33
117
2.86
7.13
3.1
2.2
—
—
—
0
0
(3013512) EKG study
415
3241
1.39
7.10
4.8
3.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
30
101
3.01
7.10
4.3
2.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
21
56
3.79
7.09
44.3
29.4
ug/l
8.3
6.9
0.51
21
48
(3035637) Corticotropin [Mass/volume] in Plasma
36
135
2.71
7.02
1.8
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
46
195
2.40
7.00
1.8
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
56
259
2.21
6.98
2.0
1.7
e6/l
29730.7
13089.3
0.66
41
191
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
31
108
2.91
6.92
1.2
1.1
u/l
74.5
53.3
0.43
22
77
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
68
342
2.04
6.84
4.0
3.3
u/ml
0.3
0.4
0.86
44
185
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
36
137
2.67
6.84
3.2
2.1
pg
33.5
32.3
1.30
36
137
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
22
63
3.53
6.72
1.3
1.3
—
46.3
—
0
8
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1048
9476
1.37
6.71
4.8
4.1
pmol/l
14.9
14.7
1.29
951
8640
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
883
7794
1.33
6.55
4.9
3.1
u/l
55.2
44.3
2.57
830
7304
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
38
153
2.52
6.47
2.7
2.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
407
3212
1.37
6.44
3.7
3.3
mg/l
656.9
286.5
0.62
247
2037
(3004616) Nuclear Ab [Presence] in Serum
35
136
2.61
6.40
1.5
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
29
102
2.88
6.38
1.3
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
144
928
1.61
6.38
5.7
3.9
ng/l
113.1
84.1
2.01
126
821
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
19
51
3.76
6.37
1.6
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
19
51
3.76
6.37
1.6
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
161
1067
1.57
6.34
6.4
3.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
36
143
2.56
6.30
1.3
1.3
—
—
—
0
0
(4034850)
71
374
1.94
6.30
11.1
9.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
139
893
1.61
6.24
4.1
3.0
ng/l
166.4
216.0
0.81
127
818
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
24
77
3.15
6.18
1.4
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
37
151
2.49
6.14
1.6
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
58
287
2.06
6.12
3.4
3.3
mmol/l
24.5
24.8
0.20
52
253
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
253
1856
1.44
6.10
3.4
2.9
e6/l
4.0
2.9
0.71
150
993
(3024522) Salmonella sp identified in Specimen by Organism specific culture
37
153
2.45
5.98
1.6
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
37
153
2.45
5.98
1.6
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
16
6.29
5.96
7.0
2.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1324
12549
1.55
5.94
24.6
12.6
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
26
90
2.92
5.90
1.4
1.1
u/ml
59.0
81.0
—
6
9
(3009508) Creatinine [Moles/volume] in Urine
442
3573
1.34
5.89
3.6
3.2
mmol/l
7.0
7.5
1.48
367
3013
(3021960) Folate [Moles/volume] in Serum or Plasma
353
2763
1.37
5.80
1.7
1.5
nmol/l
19.2
20.7
0.94
306
2347
(3000093) Morphology [Interpretation] in Blood Narrative
29
108
2.72
5.78
1.2
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
36
150
2.44
5.73
1.6
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
36
150
2.44
5.73
1.6
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
39
169
2.34
5.70
4.7
5.2
umol/l
382.6
375.9
0.10
32
149
(3005988) Vibrio sp identified in Specimen by Organism specific culture
36
151
2.42
5.66
1.6
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
10
17
5.92
5.63
3.0
1.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
419
3381
1.33
5.61
4.6
4.0
mg/mmol
9.7
8.7
0.17
258
2123
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
43
196
2.23
5.60
2.4
2.9
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
51
249
2.09
5.60
1.7
1.2
u/ml
50.8
28.0
—
7
19
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
27
99
2.76
5.54
2.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
70
384
1.86
5.53
1.3
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1185
11036
1.38
5.52
22.2
12.3
ml/min/173m2
81.5
82.8
1.04
1030
8966
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
86
503
1.75
5.51
4.8
3.0
%
0.7
0.7
1.36
80
485
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
69
378
1.87
5.48
3.6
2.7
g/l
1.5
1.4
0.07
59
335
(3003327) Ova and parasites identified in Stool by Light microscopy
75
422
1.82
5.47
1.5
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
61
321
1.94
5.46
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
38
167
2.31
5.40
1.3
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
72
402
1.83
5.39
5.0
2.5
g/l
9.7
10.4
0.51
65
345
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
16
43
3.75
5.37
7.0
4.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
43
200
2.18
5.35
3.1
2.8
—
—
—
0
0
(3036489) Thrombin time
79
455
1.78
5.34
2.4
2.6
s
21.2
21.5
0.20
72
407
(3000570) Elastase.pancreatic [Mass/mass] in Stool
64
345
1.89
5.34
1.3
1.4
ug/g
264.6
289.7
0.44
35
199
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
140
936
1.55
5.32
2.4
2.5
ug/l
6.0
6.9
0.32
116
818
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
26
96
2.74
5.28
1.2
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
44
208
2.15
5.27
1.3
1.5
mmol/l
73.0
65.3
0.53
34
170
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
19
59
3.25
5.18
1.1
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
406
3295
1.32
5.16
4.9
3.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
29
115
2.55
5.14
1.3
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
72
409
1.80
5.11
3.8
2.5
g/l
3.2
3.2
0.11
55
325
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
17
50
3.43
5.03
1.1
1.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
9
9
10.05
5.03
2.2
4.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
14
36
3.92
4.99
1.1
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
62
340
1.86
4.93
6.1
5.9
mg/l
1.5
1.5
0.01
57
315
(40768446) Kidney Pathology biopsy report
16
46
3.51
4.90
2.2
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
95
592
1.65
4.86
7.0
5.0
mmol/l
24.6
24.0
1.26
86
538
(3047181) Lactate [Moles/volume] in Blood
62
342
1.85
4.85
7.2
7.6
mmol/l
1.2
1.3
0.51
54
302
(3022806) Fractional oxyhemoglobin in Capillary blood
32
137
2.37
4.85
2.8
1.8
%
89.5
90.5
0.54
32
137
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
25
95
2.66
4.83
1.1
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
14
37
3.81
4.82
1.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
75
440
1.74
4.79
1.1
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
93
579
1.65
4.78
12.5
10.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
61
337
1.85
4.75
3.5
2.5
g/l
0.0
0.0
0.86
56
310
(3009214) Lutropin [Units/volume] in Serum or Plasma
65
368
1.80
4.69
1.6
1.5
u/l
12.8
10.0
0.77
56
294
(3022145) Colonoscopy Study observation
177
1278
1.44
4.63
1.5
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
20
69
2.92
4.61
1.4
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
20
69
2.92
4.61
1.4
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1324
12654
1.46
4.57
19.4
10.0
u/l
27.0
25.4
2.04
1296
12215
(3052851) Hemolysis interference index of Serum or Plasma
62
349
1.81
4.56
3.3
3.2
—
—
—
0
0
(3036603) Volume of Urine
21
75
2.83
4.56
1.8
1.6
ml
1969.4
2041.0
—
10
14
(3044290) Cell count panel - Cerebral spinal fluid
48
249
1.96
4.53
1.7
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
59
328
1.83
4.52
1.3
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
38
181
2.13
4.50
1.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
65
373
1.78
4.50
1.2
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
75
449
1.71
4.48
7.4
6.0
%
1.5
1.6
0.40
70
423
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
37
175
2.14
4.46
1.1
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1181
11102
1.32
4.35
5.7
4.8
mu/l
2.0
2.0
0.09
1088
10212
(3036048) Francisella tularensis Ab [Titer] in Serum
10
22
4.57
4.30
1.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1131
10586
1.30
4.19
6.6
5.5
mmol/mol
40.0
39.5
1.06
1038
9829
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
27
4.10
4.16
1.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
83
521
1.63
4.16
2.0
1.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
22
85
2.61
4.15
1.4
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
64
375
1.74
4.14
1.2
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
151
1081
1.44
4.14
3.0
2.3
u/l
35.9
39.6
0.20
128
905
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
105
699
1.54
4.11
11.6
8.8
%
1.4
1.4
0.14
100
694
(3009871) Measles virus Ab [Titer] in Serum
12
32
3.77
4.09
1.6
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
892
8132
1.25
4.04
3.7
3.2
—
—
—
0
0
(4010399)
118
810
1.50
4.01
1.6
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
26
111
2.37
4.01
1.3
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
25
105
2.40
3.99
1.8
1.2
u/ml
0.6
0.6
0.02
13
46
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
153
1109
1.42
3.93
4.5
4.1
ug/l
17.4
22.3
0.19
123
893
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
13
38
3.44
3.90
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
64
382
1.71
3.90
1.2
1.2
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
9
15
6.03
3.82
7.4
2.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
185
1393
1.38
3.81
11.8
6.9
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
12
6.70
3.67
1.3
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
16
5.65
3.66
2.7
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
9
16
5.65
3.66
1.3
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
20
79
2.55
3.64
1.4
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
13
40
3.27
3.63
1.2
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
24
104
2.33
3.60
1.6
1.3
e6/l
12903.6
105780.0
0.75
17
69
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
183
1389
1.36
3.59
4.8
4.3
%
31.8
32.3
0.23
134
937
(40768804) Tissue Pathology biopsy report
545
4755
1.23
3.58
2.2
2.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
71
447
1.62
3.56
1.5
1.3
miu/ml
217.0
248.9
0.26
27
223
(3047189) Immunofixation for 24 hour Urine
16
57
2.83
3.53
3.9
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
109
762
1.46
3.42
3.0
3.3
pmol/l
4.4
4.6
0.54
96
670
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
21
88
2.41
3.40
1.4
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
17
64
2.68
3.40
1.8
1.4
umol/l
15.1
27.6
1.38
17
58
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
18
70
2.59
3.39
1.6
1.5
u/l
3.7
8.1
0.62
11
34
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
42
3.11
3.37
1.2
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
10
27
3.72
3.35
1.1
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
27
3.72
3.35
1.2
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
12
37
3.26
3.34
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
22
95
2.34
3.34
1.2
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
21
89
2.38
3.32
1.4
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
14
48
2.94
3.30
5.6
2.0
ug/l
17.0
182.9
0.50
14
43
(36660697) Celiac disease serology panel - Serum
138
1015
1.40
3.29
1.2
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
6
7
8.60
3.26
4.3
5.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
9
19
4.76
3.24
1.3
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
267
2170
1.28
3.23
4.2
2.9
mmol/l
2.5
2.4
0.27
238
1911
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
38
3.18
3.21
1.2
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
8
15
5.36
3.19
1.1
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
27
130
2.10
3.19
1.6
1.7
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
7
11
6.39
3.18
1.7
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
16
61
2.64
3.14
1.3
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
98
686
1.46
3.08
2.1
2.1
nmol/l
12.0
12.4
0.13
88
594
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
34
3.25
3.06
2.0
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
8
7.53
3.05
2.2
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
8
7.53
3.05
2.0
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
10
29
3.47
3.05
1.1
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
84
575
1.49
2.96
12.1
9.6
mmol/l
24.3
24.3
0.01
77
539
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
24
114
2.12
2.95
1.1
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
43
250
1.74
2.94
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
43
250
1.74
2.94
1.4
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
203
1612
1.30
2.94
1.3
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
11
35
3.16
2.93
1.1
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
17
4.73
2.92
1.3
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
8
17
4.73
2.92
1.3
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
8
17
4.73
2.92
1.0
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
56
351
1.62
2.91
3.7
2.4
g/l
37.3
37.6
0.19
51
305
(3048879) Bone marrow aspiration report
10
30
3.35
2.91
1.6
1.9
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
70
2.45
2.88
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
89
2.26
2.87
1.1
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
175
1366
1.32
2.87
1.9
1.7
%
1.5
1.4
0.28
157
1206
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
41
2.94
2.86
1.2
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
12
41
2.94
2.86
3.2
3.6
—
29.8
—
0
7
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
23
109
2.13
2.85
8.9
3.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
11
36
3.07
2.81
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
17
71
2.41
2.80
1.1
1.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
15
59
2.56
2.79
1.1
1.1
u/l
39.3
14.4
1.17
15
51
(3051611) Lipemic interference index of Serum or Plasma
25
124
2.03
2.77
3.4
3.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
42
2.87
2.75
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
42
248
1.71
2.74
2.5
2.3
g/l
125.3
129.3
0.48
35
185
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
13
48
2.72
2.72
1.1
1.1
iu/ml
149.1
183.2
0.39
13
48
(3042517) Benzodiazepines panel - Urine
6
10
6.02
2.70
4.2
2.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
11
37
2.99
2.69
1.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
24
3.77
2.67
1.1
1.2
—
—
—
0
0
(4015189)
10
32
3.14
2.65
4.1
3.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
15
61
2.47
2.62
1.1
1.1
u/l
128.3
70.7
1.41
15
54
(40768441) Liver Pathology biopsy report
20
93
2.17
2.61
2.2
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
38
2.91
2.58
1.2
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
11
38
2.91
2.58
1.3
1.1
—
—
—
0
0
(3000492) Spirometry study
147
1138
1.32
2.57
1.5
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
32
178
1.82
2.57
1.8
1.5
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
5
7
7.16
2.55
3.0
1.4
mg/l
3.0
4.8
—
5
7
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
11
5.47
2.54
1.3
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
34
194
1.77
2.52
1.8
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
75
2.28
2.51
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
25
129
1.95
2.51
1.3
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
9
26
3.48
2.48
2.0
1.9
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
30
166
1.82
2.46
1.9
2.5
u/ml
4.1
29.9
0.54
30
154
(3004775) Volume in Urine collected for unspecified duration
19
89
2.15
2.45
3.3
2.4
ml
580.8
614.4
0.14
14
60
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
81
574
1.44
2.44
2.5
2.2
u/l
1475.2
5453.2
1.75
31
244
(3007461) Platelets [#/volume] in Blood
1373
13395
1.37
2.42
38.8
19.8
e9/l
255.0
253.6
0.31
1353
13052
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
12
5.02
2.40
1.0
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1066
10119
1.19
2.40
30.0
16.4
%
13.9
13.6
7.98
1057
9901
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
19
90
2.13
2.39
1.1
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
40
2.76
2.37
1.1
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
22
3.65
2.36
2.1
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
22
3.65
2.36
2.1
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
22
3.65
2.36
2.1
1.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
1373
13405
1.36
2.31
38.5
19.7
fl
91.0
90.7
1.62
1359
13221
(3035941) MCH [Entitic mass]
1373
13405
1.36
2.31
38.5
19.7
pg
30.2
30.2
0.28
1360
13219
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
9
28
3.23
2.31
1.2
1.1
%
73.9
97.5
—
9
28
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
28
3.23
2.31
1.2
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1373
13406
1.36
2.30
38.7
19.8
e12/l
4.4
4.5
11.24
1353
13027
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
32
185
1.75
2.29
1.2
1.1
iu/ml
14.0
91.0
—
9
46
(3012494) Peanut IgE Ab [Units/volume] in Serum
11
41
2.70
2.28
1.0
1.1
u/ml
2.7
18.7
—
5
26
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
13
53
2.47
2.28
2.7
2.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
25
134
1.88
2.27
1.1
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
8
23
3.49
2.27
1.4
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1373
13410
1.35
2.26
38.9
19.9
g/l
131.1
134.4
13.50
1361
13219
(3010813) Leukocytes [#/volume] in Blood
1373
13410
1.35
2.26
38.8
19.8
e9/l
7.0
6.7
2.39
1351
13022
(3051651) Icteric interference index of Serum or Plasma
17
79
2.17
2.25
3.9
3.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1147
10986
1.20
2.22
4.2
3.8
mmol/l
1.3
1.3
2.27
1043
10084
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
44
281
1.58
2.19
1.7
1.7
e6/l
69.2
1422.2
0.78
37
227
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
44
281
1.58
2.19
1.7
1.6
e6/l
37.4
14.5
0.45
35
220
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
19
3.70
2.15
1.4
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
14
61
2.31
2.15
1.6
1.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
43
2.57
2.10
1.8
1.6
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
31
2.91
2.07
1.0
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
103
1.95
2.05
1.9
1.3
e6/l
24541.7
108867.6
0.70
14
55
(3024891) Influenza virus A+B Ag [Presence] in Specimen
50
335
1.51
2.03
1.1
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
38
2.64
2.01
3.3
2.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
57
396
1.46
1.95
4.1
3.2
u/ml
8842.9
1153.4
0.47
45
337
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
11
4.56
1.94
1.6
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
11
45
2.46
1.93
4.5
2.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
162
1323
1.25
1.92
1.5
1.4
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
13
58
2.25
1.91
1.5
1.6
—
11.7
—
0
5
(3017817) Protein [Mass] in Urine collected for unspecified duration
20
107
1.88
1.86
2.6
2.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
28
2.87
1.86
1.1
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
23
129
1.80
1.86
2.5
2.3
mg/l
16.8
26.6
—
5
31
(3003888) Timothy IgE Ab [Units/volume] in Serum
39
253
1.56
1.85
1.1
1.1
u/ml
6.3
7.4
0.12
24
145
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
17
3.54
1.84
1.0
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
23
3.05
1.80
4.9
5.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
44
297
1.50
1.76
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
52
730
0.70
1.75
1.1
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
16
81
1.99
1.75
1.3
1.0
u/ml
12.2
0.4
—
7
26
(44816559) Phosphatidylethanol [Mass/volume] in Blood
37
241
1.55
1.74
1.4
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
854
8065
1.14
1.72
4.6
3.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
13
61
2.14
1.71
4.5
2.5
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
13
3.86
1.71
8.6
6.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
18
96
1.89
1.71
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
18
96
1.89
1.71
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
92
712
1.31
1.69
1.3
1.4
—
—
—
0
0
(4268621)
22
126
1.76
1.68
2.1
2.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
12
55
2.19
1.67
1.3
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
12
55
2.19
1.67
1.5
1.1
miu/ml
1667.4
1581.6
0.07
12
55
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
18
97
1.87
1.66
1.1
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
31
2.59
1.66
2.4
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
25
2.81
1.65
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
25
2.81
1.65
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
25
2.81
1.65
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
25
2.81
1.65
1.1
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
15
76
1.98
1.64
1.4
1.1
u/ml
9.3
0.7
—
7
30
(3024263) Appearance of Synovial fluid
11
49
2.25
1.63
1.7
1.7
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
5
14
3.58
1.61
1.6
1.1
u/l
9.6
29.0
—
5
9
(3000330) Specific gravity of Urine by Test strip
76
577
1.33
1.60
5.6
3.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
43
296
1.47
1.59
6.7
4.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
19
324
0.58
1.58
1.4
1.4
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
16
85
1.89
1.55
1.0
1.1
iu/ml
11.1
8.9
—
8
23
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
44
2.28
1.53
1.2
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
19
321
0.59
1.53
1.4
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
22
131
1.69
1.50
1.1
1.2
nmol/l
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
92
1154
0.78
1.48
1.4
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
20
329
0.60
1.46
1.4
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
11
52
2.12
1.44
1.2
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
14
73
1.93
1.44
1.1
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
21
125
1.69
1.44
1.5
2.0
—
—
—
0
0
(4211845)
12
59
2.04
1.43
3.3
2.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
61
457
1.35
1.43
1.5
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1168
11327
1.15
1.40
5.2
4.3
mmol/l
6.0
5.9
1.49
1058
10315
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1183
11483
1.15
1.40
4.6
4.2
mmol/l
4.6
4.7
2.01
1090
10664
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
10
46
2.18
1.40
1.5
1.7
—
1224630.0
—
0
5
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
17
96
1.78
1.39
1.1
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
29
190
1.54
1.38
1.1
1.1
u/ml
5.9
4.1
0.42
15
67
(3003434) Protein [Mass/volume] in Pleural fluid
22
135
1.64
1.36
1.7
1.3
g/l
32.5
32.4
0.01
22
121
(3023323) Follitropin [Units/volume] in Serum or Plasma
79
620
1.29
1.35
1.6
1.4
iu/l
27.8
25.9
0.21
71
528
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
38
265
1.45
1.35
3.6
2.5
ug/min
63.6
113.3
0.59
24
167
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
37
0.00
1.34
0.0
1.4
—
15.1
—
0
26
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1201
11681
1.15
1.34
5.1
4.7
mmol/l
2.7
2.8
0.98
1101
10773
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
75
587
1.29
1.32
2.6
2.4
—
—
—
0
0
(4024509)
17
99
1.73
1.27
1.2
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
194
1.50
1.27
1.1
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
21
130
1.62
1.27
1.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
25
2.41
1.24
2.7
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
36
2.23
1.24
2.1
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
26
171
1.53
1.23
1.0
1.1
u/ml
5.8
6.0
0.02
14
63
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
45
330
1.38
1.23
2.2
1.9
iu/l
5.6
5.4
0.04
15
118
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1172
11400
1.14
1.22
4.6
4.2
mmol/l
1.4
1.5
4.38
1072
10519
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
19
2.64
1.21
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
37
2.17
1.21
1.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
35
247
1.43
1.19
1.1
1.1
u/ml
0.7
1.7
0.84
20
118
(3047007) Chlamydophila sp Ab [Presence] in Serum
28
189
1.49
1.19
1.1
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
26
2.31
1.18
1.5
1.3
—
—
—
0
0
(3019977) pH of Arterial blood
11
57
1.94
1.17
1.7
3.6
ph
7.4
7.4
—
5
15
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
54
412
1.32
1.16
1.6
1.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
1.5
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
3.2
—
1.9
—
0
25
(3011288) Drugs identified in Urine by Screen method
50
379
1.33
1.13
3.1
2.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
29
200
1.46
1.12
1.5
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
40
2.01
1.12
2.0
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
23
151
1.53
1.12
1.5
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
10
51
1.97
1.11
3.8
2.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
13
73
1.79
1.11
2.9
1.6
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
96
1.67
1.10
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
96
1.67
1.10
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
96
1.67
1.10
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
29
201
1.45
1.10
1.5
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
12
66
1.82
1.09
1.8
1.2
u/l
9.7
12.3
0.42
12
57
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
27
185
1.47
1.09
1.3
1.2
u/ml
3.8
5.6
0.39
12
77
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
11
59
1.87
1.07
1.7
2.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
30
211
1.43
1.06
3.4
3.2
nmol/l
0.8
0.8
0.02
23
165
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
38
279
1.37
1.06
1.2
1.1
u/ml
0.7
1.9
1.10
21
119
(3036071) Salmonella sp Ab [Titer] in Serum
9
46
1.96
1.03
1.2
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
16
98
1.64
1.03
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
21
138
1.53
1.03
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
17
106
1.61
1.03
1.9
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
177
0.56
1.02
1.3
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
24
164
1.47
0.99
1.1
1.0
u/ml
0.1
0.5
0.79
11
38
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
76
1.72
0.99
1.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
23
2.18
0.98
1.6
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
16
100
1.61
0.97
1.9
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
27
2.23
0.93
1.0
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
27
2.23
0.93
2.7
5.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
27
2.23
0.93
1.3
2.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
29
2.07
0.89
2.3
1.8
—
—
—
0
0
(4306422)
23
160
1.44
0.89
1.3
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
374
3476
1.10
0.88
1.6
1.5
—
—
—
0
0
(44813793)
14
87
1.62
0.87
1.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
24
333
0.72
0.86
1.7
1.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
32
239
1.35
0.84
1.1
1.1
u/ml
5.3
3.0
0.34
11
54
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
55
443
1.25
0.84
1.5
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
293
2697
1.11
0.84
5.2
5.1
ug/l
2.9
3.2
0.14
258
2397
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
64
775
0.82
0.83
1.6
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
138
0.58
0.83
1.3
1.7
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
6
32
1.88
0.82
1.5
1.2
mmol/l
2.3
3.5
—
6
27
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
81
1.61
0.81
1.0
2.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
24
172
1.40
0.81
1.3
1.1
—
—
—
0
0
(4133840)
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
84
716
1.18
0.76
1.0
1.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
14
91
1.54
0.75
2.2
1.4
promille
0.8
1.2
—
9
74
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
24
2.09
0.74
2.0
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
89
1031
0.85
0.73
1.3
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
34
435
0.78
0.73
1.4
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
35
272
1.29
0.73
2.3
2.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
25
2.00
0.72
1.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
31
400
0.77
0.72
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
31
399
0.77
0.71
1.5
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
67
564
1.20
0.71
2.5
1.9
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
26
1.93
0.70
2.0
3.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
5
26
1.93
0.70
1.0
1.0
u/ml
63.7
42.8
—
5
26
(3004451) EKG impression Narrative
9
58
1.56
0.69
1.0
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
56
464
1.22
0.69
2.8
1.7
mg/l
4.6
3.3
0.67
42
332
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
239
2201
1.10
0.69
1.5
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
66
556
1.20
0.69
2.5
1.9
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
19
135
1.41
0.69
2.5
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
67
566
1.19
0.68
2.5
1.9
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
31
397
0.78
0.68
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
31
397
0.78
0.68
1.5
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
27
1.85
0.68
4.4
7.4
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
5
27
1.85
0.68
1.2
1.2
—
49.2
—
0
13
(3035880) pH of Pleural fluid
9
59
1.53
0.68
1.3
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
103
906
1.15
0.65
1.2
1.2
iu/ml
78.5
141.1
2.16
37
356
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
172
1563
1.11
0.65
2.1
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
66
561
1.18
0.64
2.5
1.9
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
29
1.73
0.64
4.4
7.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
76
655
1.17
0.63
1.8
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
62
525
1.19
0.63
2.6
2.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
121
1.41
0.62
1.1
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
234
2168
1.09
0.61
4.2
4.4
%
21.2
21.5
0.10
121
1065
(3013139) Helicobacter pylori Ag [Presence] in Stool
91
799
1.15
0.60
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
162
1478
1.11
0.58
1.8
1.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
36
1.67
0.56
2.2
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
36
1.67
0.56
2.2
2.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
23
296
0.77
0.55
1.5
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
42
504
0.83
0.55
1.7
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
38
1.58
0.54
1.8
1.2
ug/l
8.9
9.1
—
6
38
(40768806) Pleura Pathology biopsy report
15
109
1.38
0.51
2.2
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
47
398
1.19
0.51
1.9
2.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
67
1.50
0.49
1.1
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1130
11123
1.07
0.49
25.5
14.5
%
39.0
39.6
1.46
766
8125
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
47
1.49
0.47
1.6
1.7
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
15
111
1.35
0.46
1.1
1.5
mmol/l
8.3
11.9
—
7
21
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
169
1569
1.09
0.45
3.4
3.1
ug/l
0.8
0.8
0.00
124
1051
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
220
0.77
0.45
1.6
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
30
247
1.22
0.44
2.5
2.3
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
32
1.56
0.42
1.4
1.1
pmol/l
237.2
295.1
—
5
21
(3020650) Glucose [Presence] in Urine
5
32
1.56
0.42
1.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
16
206
0.77
0.41
1.6
1.6
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
15
0.00
0.41
0.0
2.9
—
0.7
—
0
15
(3028717) Thiamine [Mass/volume] in Blood
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
319
3047
1.06
0.40
1.7
1.7
mmol/l
1.5
1.4
1.09
265
2578
(3051101) Glucose [Moles/volume] in Cord blood
0
18
0.00
0.40
0.0
6.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
18
0.00
0.40
0.0
1.2
—
1.6
—
0
18
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
30
251
1.20
0.39
3.0
1.8
nmol/l
1.3
0.8
1.16
18
209
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
17
134
1.27
0.37
4.7
2.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
29
244
1.19
0.36
3.3
3.9
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
23
189
1.22
0.36
1.3
1.1
u/ml
2.5
1.9
—
8
60
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
90
1.34
0.36
2.9
1.6
g/l
1.0
1.0
0.02
12
90
(3002256) Pathology report gross observation
158
1482
1.07
0.35
1.3
1.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
10
73
1.37
0.34
10.0
10.3
mmol/l
0.7
0.6
—
10
68
(3036782) Glucose [Moles/volume] in Pleural fluid
13
101
1.29
0.31
1.7
1.3
mmol/l
6.6
6.7
0.04
13
93
(3023511) Choriogonadotropin [Units/volume] in Urine
38
333
1.14
0.31
1.2
1.3
—
—
—
0
0
(4198724)
7
52
1.35
0.31
2.0
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
52
1.35
0.31
1.1
3.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
50
447
1.12
0.31
2.6
1.9
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
53
1.32
0.31
1.1
1.0
—
—
—
0
0
(4146454)
14
112
1.25
0.28
2.7
2.8
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
29
252
1.15
0.27
1.2
1.7
nmol/l
44.4
40.5
0.39
29
243
(1002224) Polysomnography panel
42
468
0.89
0.26
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
23
198
1.16
0.24
1.3
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
76
1.19
0.24
1.3
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
38
1.32
0.23
1.2
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
22
190
1.16
0.23
1.0
1.0
u/ml
1.7
2.2
—
8
83
(3051593) INR in Capillary blood by Coagulation assay
5
40
1.25
0.22
1.4
11.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
15
125
1.20
0.22
1.3
1.1
%
95.9
95.9
0.00
15
117
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.3
—
35.3
—
0
6
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
11.9
—
—
—
0
0
(4027681)
11
89
1.24
0.21
1.3
1.3
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
13
0.00
0.21
0.0
5.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
35
386
0.90
0.20
1.5
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
179
1729
1.04
0.17
2.3
2.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
22
195
1.13
0.17
1.3
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
63
1.11
0.17
7.4
7.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
19
168
1.13
0.15
1.4
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
172
0.87
0.15
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
84
1.19
0.14
3.7
2.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
9
106
0.85
0.13
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
23
252
0.91
0.12
4.0
3.4
mg/l
21.9
25.6
0.31
15
160
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
107
1.12
0.08
1.4
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
63
0.79
0.08
1.0
3.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
7
67
1.04
0.08
2.4
1.7
u/field
0.3
4.9
—
7
50
(1761868) Lipid panel - Serum or Plasma
411
4069
1.01
0.07
2.9
2.7
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
6
73
0.82
0.07
1.0
1.4
nmol/l
28.3
33.2
—
6
61
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
81
0.86
0.07
1.6
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
94
0.85
0.06
1.4
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
45
466
0.96
0.05
1.5
1.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
29
304
0.95
0.05
1.4
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
140
1378
1.02
0.05
1.7
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
80
783
1.02
0.05
2.9
2.8
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
19
201
0.94
0.04
1.9
2.3
umol/l
4.5
6.2
0.57
11
146
(4094501)
27
281
0.96
0.04
1.1
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1026
10282
0.99
0.03
32.1
17.4
g/l
331.0
332.3
4.73
1014
10202
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
42
430
0.98
0.02
1.5
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
93
1.08
0.02
3.9
4.8
%
12.3
11.3
—
10
93
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
84
831
1.01
0.01
1.8
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
103
1036
0.99
0.00
1.9
1.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
132
0.98
0.00
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
21
212
0.99
0.00
1.5
1.5
nmol/l
0.2
0.3
1.44
13
170
(4281824)
13
127
1.02
0.00
1.3
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
44.2
—
0
5
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
8
0.00
0.00
0.0
1.1
—
7.9
—
0
8
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
71
0.99
0.00
1.3
1.3
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
59
0.85
0.00
1.8
1.3
nmol/l
115.0
138.3
—
5
59
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(4038314)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
56
0.89
0.00
1.0
1.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint GENERALI_SKIN_ERUPT_DRUGS_MEDICAM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| GENERALI_SKIN_ERUPT_DRUGS_MEDICAM | 1.819 [1.6, 2.07] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.29 |
During the follow-up period (1.1.1998 — 31.12.2019), 1245 out of 5640 females with GENERALI_SKIN_ERUPT_DRUGS_MEDICAM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| GENERALI_SKIN_ERUPT_DRUGS_MEDICAM | 2.073 [1.77, 2.43] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 840 out of 3833 males with GENERALI_SKIN_ERUPT_DRUGS_MEDICAM died.
Mortality risk
Mortality risk for people of age
years, who have GENERALI_SKIN_ERUPT_DRUGS_MEDICAM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.171% | 0.399% |
| 5 | 0.945% | 2.288% |
| 10 | 2.696% | 5.745% |
| 15 | 5.097% | 10.828% |
| 20 | 8.893% | 17.877% |
Relationships between endpoints
↥Index endpoint: GENERALI_SKIN_ERUPT_DRUGS_MEDICAM – Generalized skin eruption due to drugs and medicaments
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data